May 22, 2024 – Page 6 – Goldea Capital

HydroGraph Announces $1.6 Million Private Placement

Written by Customer Service on May 22, 2024. Posted in Public Companies.

Not for distribution to U.S. newswire services or dissemination in the United States.All dollar amounts are in Canadian dollars unless otherwise indicated‎. VANCOUVER, British Columbia, May 22, 2024 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: ‎HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”), a commercial manufacturer of high-‎quality graphene and other nanomaterials, ‎is pleased to announce that it intends to complete a non-brokered private placement of units of the Company (the “Units”), at a price of $0.16 per Unit, for aggregate gross proceeds of up to $1,600,000 (the “Offering”). Each Unit will consist of one common share in the capital of the Company (each, a “Common Share”) and one-half of one Common Share purchase warrant of the Company (each whole warrant, a “Warrant”). Each Warrant will entitle the holder thereof...

Andes Technology and Arteris Partner To Accelerate RISC-V SoC Adoption

Written by Customer Service on May 22, 2024. Posted in Public Companies.

Highlights: Andes Technology and Arteris partnership aims to support the growing adoption of RISC-V SoCs by mutual customers. Focus is on high-performance/low-power RISC-V-based designs across a wide range of markets, including consumer electronics, communications, industrial applications and AI. The collaboration showcases integrated and optimized solutions with leading Andes RISC-V processor IPs and Arteris interconnect IP in silicon. CAMPBELL, Calif., May 22, 2024 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP that accelerates system-on-chip (SoC) creation and Andes Technology (TWSE: 6533), a founding and premier member of RISC-V International and a leading supplier of high-performance/low-power RISC-V processor IP, today announced their partnership to advance innovation for RISC-V based SoC...

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

Written by Customer Service on May 22, 2024. Posted in Public Companies.

NEW HOPE, Pa., May 22, 2024 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will present and be available for one-on-one meetings at the Jefferies Global Healthcare Conference being held in New York, NY, June 4-6, 2024. Details of the presentation are below. Format: Fireside Chat Date: Wednesday, June 5, 2024 Time: 4:00 PM ET (Track 1) Webcast: https://wsw.com/webcast/jeff302/obio/1835536 A replay of the webcast will be available on the Events section of the Orchestra BioMed website for 90 days following the presentation. About Orchestra BioMedOrchestra BioMed (Nasdaq: OBIO) is a biomedical innovation company accelerating...

First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology

Written by Customer Service on May 22, 2024. Posted in Public Companies.

ST. LOUIS, May 22, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy. Patients suffering from heart rhythm disorders are now being successfully treated with robotic ablation procedures using this advanced technology, and Hospital Santa Maria della Pietà is the first hospital in Italy to adopt the cutting-edge Genesis Robotic Magnetic Navigation (RMN) system. “As electrophysiologists, our primary goal is to improve the lives of our patients,” said Dr. Mario Volpicelli, Head of the Electrophysiology Unit of the hospital. “With the Genesis RMN system, we now have an unprecedented level...

AITX Unveils AIR™ as the Core of Its Operations, Revolutionizing Industry Standards with Advanced Autonomous Solutions

Written by Customer Service on May 22, 2024. Posted in Public Companies.

AIR Manifesto Now Available on AITX Website Detroit, Michigan, May 22, 2024 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), is excited to announce that AIR™ (Autonomous Intelligent Response) has become the core paradigm driving all client solutions across AITX and its subsidiaries. Fully detailed and downloadable on the AITX website as of today, AIR represents the concepts and applications that integrate artificial intelligence with autonomous response capabilities across various security and facility management applications and devices. AIR is the cumulation of years of development and experience and is aimed to transform and elevate the efficiency and effectiveness of security operations by leveraging advanced AI and machine learning technologies. This platform produces...

NeurAxis Reports First Quarter 2024 Financial Results

Written by Customer Service on May 22, 2024. Posted in Earnings Releases And Operating Results.

CARMEL, Ind., May 22, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the first quarter 2024 for the period ended March 31, 2024. Recent Operational Highlights Expanded total covered lives to approximately 22.5 million covered lives, an increase of 400% compared to 4.5 million covered lives as of May 1, 2023. Recent medical policy coverages include: BCBS licensee in Florida covering over 6 million lives. BCBS licensee in North Dakota covering over 310,000 people. BCBS plan in the mid-Atlantic region, providing coverage for approximately 7 million covered lives. Medical Policy with a BCBS licensee covering approximately 1...

CVRx to Present at the William Blair 44th Annual Growth Stock Conference

Written by Customer Service on May 22, 2024. Posted in Public Companies.

MINNEAPOLIS, May 22, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, today announced that the management team will present at the William Blair 44th Annual Growth Stock Conference on Wednesday, June 5, 2024. The Company is scheduled to present at 8:40am Central Time the same day via webcast. A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.cvrx.com. About CVRx, Inc. CVRx is focused on the development and commercialization of the Barostim™ System, the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid...

Veru to Present at the Jefferies Global Healthcare Conference

Written by Customer Service on May 22, 2024. Posted in Public Companies.

MIAMI, FL, May 22, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present an update of Veru’s Phase 2b clinical program of enobosarm to augment fat loss and to avoid muscle loss when combined with GLP-1 drugs for weight loss at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 am – 11:25 am ET. A live webcast will be accessible through the Investors section of the Company’s website at www.verupharma.com. Following the event, an archived webcast will be available on the Veru website. About...

Mobiquity Technologies Announces Strategic Collaboration with MW Political for Advanced Political Advertising Solutions

Written by Customer Service on May 22, 2024. Posted in Public Companies.

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) — Mobiquity Technologies, Inc. (OTC: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions, announces a strategic collaboration with MW Political, leveraging our combined expertise in political data and advertisements across Connected TV (CTV) and Over-The-Top (OTT) platforms. This collaboration marks a significant milestone in delivering advanced digital advertising solutions in the political arena. The collaboration has already paved the way for substantial business opportunities. Beginning mid-July 2024, based upon contracts received by MW Political, together we anticipate launching new political advertising campaigns valued at an estimated $7 million dollars over the next four years. These campaigns, spearheaded by our esteemed...

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility

Written by Customer Service on May 22, 2024. Posted in Public Companies.

SCD’s ability to improve clinical status of four critically ill pediatric and adult patients across multiple clinical conditions published in Transplantation Direct DENVER, May 22, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces the publication of a manuscript citing four case studies in which critically ill patients between the ages of 22 months and 71 years with multiorgan failure who were treated with the Selective Cytopheretic Device (SCD) successfully stabilized and improved their clinical status prior to stem cell or liver transplant, or left ventricular assist device implantation. The abstract was published in peer-reviewed Transplantation Direct,...

Day: May 22, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice